Alzheimer's disease (AD) is the most common cause of dementia, affecting the central
nervous system (CNS) through the accumulation of intraneuronal neurofibrillary tau tangles …

Background Mild cognitive impairment (MCI) due to Alzheimer's disease is the symptomatic
predementia phase of Alzheimer's disease dementia, characterised by cognitive and …

Abstracts Background The retina and brain share many neuronal and vasculature
characteristics. We investigated the retinal microvasculature in Alzheimer's disease (AD) …

The trail-making test (TMT) is a popular neuropsychological test, which is used extensively
to measure cognitive impairment associated with neurodegenerative disorders in older …

Objective Efficient prediction of the progression of mild cognitive impairment (MCI) to
Alzheimer's disease (AD) is important for the early intervention and management of AD. The …

Background We sought to investigate the possible associations of rest-activity patterns with
cortical amyloid burden, medial temporal lobe (MTL) neurodegeneration, and cognitive …

Background: Structural magnetic resonance imaging (MRI) is routinely performed in patients
with mild cognitive impairment (MCI), but diagnostic accuracy to detect early cerebral …

Background: Visual rating scales for medial temporal lobe atrophy (MTA) and posterior
atrophy (PA) have been reported to be useful for Alzheimer's disease diagnosis in routine …

Alzheimer's disease is the absolute generous of age-related neurodegenerative syndrome.
It specifies substantial brain atrophy, amnesia and major neuro-logic disintegration. Brain …

INTRODUCTION—Mild cognitive impairment (MCI) is an intermediate clinical state between
normal cognition and dementia. While specific subtle changes in cognition are frequently …